| Literature DB >> 36200122 |
Luiz Fernando Norcia1, Erika Mayumi Watanabe2, Pedro Tadao Hamamoto Filho3, Claudia Nishida Hasimoto1, Leonardo Pelafsky1, Walmar Kerche de Oliveira1, Ligia Yukie Sassaki4.
Abstract
Polycystic liver disease (PLD) is a clinical condition characterized by the presence of more than 10 cysts in the liver. It is a rare disease Of genetic etiology that presents as an isolated disease or assoc\iated with polycystic kidney disease. Ductal plate malformation, ciliary dysfunction, and changes in cell signaling are the main factors involved in its pathogenesis. Most patients with PLD are asymptomatic, but in 2-5% of cases the disease has disabling symptoms and a significant reduction in quality of life. The diagnosis is based on family history of hepatic and/or renal polycystic disease, clinical manifestations, patient age, and polycystic liver phenotype shown on imaging examinations. PLD treatment has evolved considerably in the last decades. Somatostatin analogues hold promise in controlling disease progression, but liver transplantation remains a unique curative treatment modality.Entities:
Keywords: hepatomegaly; liver; liver cysts; polycystic liver disease; therapeutics
Year: 2022 PMID: 36200122 PMCID: PMC9528914 DOI: 10.2147/HMER.S377530
Source DB: PubMed Journal: Hepat Med ISSN: 1179-1535